Home/Filings/4/0001724521-25-000018
4//SEC Filing

Jarrett Jennifer 4

Accession 0001724521-25-000018

CIK 0001724521other

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 4:30 PM ET

Size

7.0 KB

Accession

0001724521-25-000018

Insider Transaction Report

Form 4
Period: 2025-01-23
Jarrett Jennifer
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2025-01-23+50,000213,369 total
  • Award

    Stock Option (right to buy)

    2025-01-23+200,000200,000 total
    Exercise: $13.33Exp: 2035-01-22Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company.
  • [F2]The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001671311

Filing Metadata

Form type
4
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 4:30 PM ET
Size
7.0 KB